Method and system for determining HPV integration site in genome from human cervical carcinoma sample

A technology for human cervical cancer and integration sites, which is applied to the field of determining HPV integration sites in the genome of human cervical cancer samples, can solve the problems of difficult to find integration sites, unfavorable integration conditions, and needs to be improved, and achieves easy preparation and operation, The effect of low production and use cost and simple structure

Active Publication Date: 2013-09-25
BGI BIOTECH WUHAN CO LTD
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these methods can only detect one HPV type at a time, or have other technical deficiencies, such as the signal detection problem of in situ hybridization and the harsh conditions of PCR analysis, which are not conducive to the detection of complex integration situations
The above traditional methods are not only time-consuming and laborious, but also difficult to discover new integration sites
[0004] Therefore, at this stage, the method for determining the HPV integration site in the genome of human cervical cancer samples still needs to be improved.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and system for determining HPV integration site in genome from human cervical carcinoma sample
  • Method and system for determining HPV integration site in genome from human cervical carcinoma sample
  • Method and system for determining HPV integration site in genome from human cervical carcinoma sample

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] refer to figure 1 According to the method of the present invention, the HPV integration site in the genome of the human cervical cancer sample to be tested is determined according to the following steps:

[0044] (1) Preparation of sample DNA

[0045] Sample information: A 47-year-old Chinese female patient with no relevant medical history or familial cervical cancer genetic history. The main clinical symptom is abnormal vaginal bleeding for up to 6 months. Cytology revealed HSIL (high-grade squamous intraepithelial lesion). In the HC2 test, the foci of HR-HPV infection tested positive. Biopsy specimen showed postoperative squamous cell carcinoma tumor tissue.

[0046] Human cervical cancer samples (including blood, cancer tissue and paracancerous tissue) were collected, DNA was extracted separately and purified using standard methods.

[0047] (2) Library construction and sequencing

[0048] Use the Illumina library construction method to construct a library with...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method and a system for determining HPV integration site in genome from a human cervical carcinoma sample. The method provided by the invention comprises the following steps: carrying out first sequencing on genomic DNA from a human cervical carcinoma sample so as to obtain a sequencing result; determining a DNA fragment containing both HPV sequence and human genomic sequence based on the sequencing result; determining an amplification primer pair based on the DNA fragment containing both HPV sequence and human genomic sequence; carrying out PCR amplification on the genomic DNA from the human cervical carcinoma sample by the utilization of the amplification primer pair so as to obtain a PCR product; and carrying out second sequencing on the PCR product so as to determine the HPV integration site in the genome from the human cervical carcinoma sample. The method provided by the invention is simple and easy to operate, requires low cost, and has high efficiency and good repeatability. By the utilization of the method, all HPV types can be detected at a time, and detailed sequence information and the integration site can be determined rapidly and accurately.

Description

technical field [0001] The present invention relates to a method and a system for determining the HPV integration site in the genome of a human cervical cancer sample. Background technique [0002] Human papillomavirus (HPV for short) is a closed circular deoxyribonucleotide virus. 118 subtypes have been found so far. Among them, virus subtypes related to human malignant tumors include 5, 6, 8, 11, 16, 18, 31, 33 and other types. The viral oncogenes (such as E6, E7) carried by them will be integrated into the host genome along with the viral DNA during the early development of cancer, resulting in changes in the expression of these two oncogenes (E6, E7). The proteins p53(E6) and pRB(E7) encoded by these two genes accelerate the degradation of host cells and contribute greatly to the oncogenicity of HR-HPV. These two oncoproteins interfere with the replication and segregation machinery during chromosome mitosis, inducing severe chromosomal instability. Studies have confi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68C12M1/34
CPCC12Q1/708C12Q1/6886C12Q2600/156
Inventor 严志祥游丽金操利超肖萍张勇
Owner BGI BIOTECH WUHAN CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products